India Globalization Capital, Inc. (NYSEMKT:IGC) is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions. In support of this mission, IGC has assembled a portfolio of patent filings for its phytocannabinoid-based treatments. The company is based in Bethesda, Maryland.
Various public companies are accomplishing the two-fold mission of improving the health of our four-footed friends while giving investors the opportunity to capitalize on a multibillion-dollar industry. India Globalization (NYSE:IGC), VCA, Inc. (NASDAQ:WOOF), PetMed Express (NASDAQ:PETS), Blue Buffalo (NASDAQ:BUFF) and IDEXX Laboratories (NASDAQ:IDXX) are just some of the companies blazing lucrative trails in the pet health market.
